Carmot Therapeutics
Research Services2-10 Employees
Learn about working at Carmot Therapeutics. Join LinkedIn today for free. See who you know at Carmot Therapeutics, leverage your professional network, and get hired.
Insights
Acquisition by Morningstar Carmot Therapeutics has been acquired by Morningstar, presenting potential cross-selling opportunities through Morningstar's diversified product portfolio and client base.
Public Listing Following its public listing, Carmot Therapeutics is now positioned to attract new investors and strategic partners, creating opportunities for business development and fundraising initiatives.
Phase II Trials of CT-868 With the launch of phase 2 trials for CT-868, Carmot Therapeutics is entering a crucial stage in its drug development process, offering potential partnerships for clinical trial collaborations and licensing opportunities.
Executive Appointments The recent appointments of key executives like Michael Gray as COO and CFO indicate Carmot Therapeutics' focus on leadership enhancement, potentially paving the way for new business strategies and market positioning.
IPO Consideration Reports suggest Carmot Therapeutics is considering an IPO or sale to a pharmaceutical giant at a valuation of $1B, hinting at future investment opportunities and possible M&A activities in the industry.
Similar companies to Carmot Therapeutics
Goldfinch Bio
11
$10MAligos Therapeutics
82$10M$50MHARBOUR BIOMED
201$50M$100MCarisma Therapeutics
85$10M$50MAmbys Medicines
51$10M$50MSurrozen
74$10M
Carmot Therapeutics Tech Stack
Carmot Therapeutics uses 8 technology products and services including MySQL, Shopify, jQuery, and more. Explore Carmot Therapeutics's tech stack below.
- MySQLDatabase
- ShopifyE-commerce
- jQueryJavascript Libraries
- HTTP/3Miscellaneous
- Yoast SEOSearch Engines
- Cloudflare Bot ManagementSecurity
- Google Tag ManagerTag Management
- JetpackWeb Platform Extensions
Media & News
Carmot Therapeutics's Email Address Formats
Carmot Therapeutics uses at least 1 format(s):
| Carmot Therapeutics Email Formats | Percentage |
| FLast@carmot.us | 28% |
| First.Last@carmot.us | 22% |
| FLast@carmot.us | 28% |
| First.Last@carmot.us | 22% |
Frequently Asked Questions
What is Carmot Therapeutics's phone number?
You can contact Carmot Therapeutics's main corporate office by phone at +1-415-978-****
What is Carmot Therapeutics's stock symbol?
Carmot Therapeutics is a publicly traded company; the company's stock symbol is CRMO. What is Carmot Therapeutics's official website and social media links?
Carmot Therapeutics's official website is carmot.us and has social profiles on LinkedIn.How much revenue does Carmot Therapeutics generate?
As of August 2020, Carmot Therapeutics's annual revenue reached $489K. What is Carmot Therapeutics's SIC code NAICS code?
Carmot Therapeutics's SIC code is 5094 - Jewelry, Watches, Precious Stones, and Precious Metals NAICS code is 5417 - Scientific Research and Development Services.How many employees does Carmot Therapeutics have currently?
As of August 2020, Carmot Therapeutics has approximately 10 employees across 1 continents, including North America. Key team members include Head Of Legal, Corporate Secretary: M. P.Vice President, Commercial Strategy: E. C.Vice President, Clinical Operations: M. E.. Explore Carmot Therapeutics's employee directory with LeadIQ.What industry does Carmot Therapeutics belong to?
Carmot Therapeutics operates in the Research Services industry. What technology does Carmot Therapeutics use?
Carmot Therapeutics's tech stack includes MySQLShopifyjQueryHTTP/3Yoast SEOCloudflare Bot ManagementGoogle Tag ManagerJetpack. What is Carmot Therapeutics's email format?
Carmot Therapeutics's email format typically follows the pattern of . Find more Carmot Therapeutics email formats with LeadIQ. 
Company Overview
- Phone number
- +1-415-978-****
- Website
- carmot.us
- SIC Code
- 5094 - Jewelry, Watches, Precious Stones, and Precious Metals
- Stock Symbol
- CRMO
- NAICS Code
- 5417 - Scientific Research and Development Services
- Employees
- 2-10
Funding & Financials
- $10M
Carmot Therapeutics's revenue is in the range of $10M
Funding & Financials
- $10M
Carmot Therapeutics's revenue is in the range of $10M
Company Leadership
M. P.Head Of Legal, Corporate Secretary
E. C.Vice President, Commercial Strategy- M. E.Vice President, Clinical Operations
R. V. D.Vp, Clinical Development- A. S.Senior Medical Director
Employee Directory
- S. T. T.Clinical Trial Manager
- A. S.Scientist
- J. M.Scientist
- J. E.Scientist
- S. P.Scientist I
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
